サワイグループホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/04/06 | 3,685 | 3,715 | 3,670 | 3,700 | +10 | +0.3% | 111,600 |
| 2023/04/05 | 3,740 | 3,740 | 3,680 | 3,690 | -45 | -1.2% | 107,300 |
| 2023/04/04 | 3,695 | 3,735 | 3,670 | 3,735 | +50 | +1.4% | 104,000 |
| 2023/04/03 | 3,685 | 3,685 | 3,655 | 3,685 | +35 | +1% | 68,600 |
| 2023/03/31 | 3,640 | 3,675 | 3,630 | 3,650 | +15 | +0.4% | 105,500 |
| 2023/03/30 | 3,685 | 3,690 | 3,620 | 3,635 | -80 | -2.2% | 95,700 |
| 2023/03/29 | 3,700 | 3,715 | 3,675 | 3,715 | +40 | +1.1% | 131,400 |
| 2023/03/28 | 3,685 | 3,690 | 3,665 | 3,675 | +15 | +0.4% | 55,100 |
| 2023/03/27 | 3,660 | 3,680 | 3,640 | 3,660 | +20 | +0.5% | 119,900 |
| 2023/03/24 | 3,590 | 3,640 | 3,590 | 3,640 | +30 | +0.8% | 87,400 |
| 2023/03/23 | 3,575 | 3,625 | 3,555 | 3,610 | +10 | +0.3% | 142,700 |
| 2023/03/22 | 3,615 | 3,625 | 3,570 | 3,600 | +35 | +1% | 128,900 |
| 2023/03/20 | 3,630 | 3,635 | 3,565 | 3,565 | -85 | -2.3% | 160,400 |
| 2023/03/17 | 3,650 | 3,655 | 3,625 | 3,650 | +35 | +1% | 164,300 |
| 2023/03/16 | 3,615 | 3,645 | 3,600 | 3,615 | -45 | -1.2% | 135,600 |
| 2023/03/15 | 3,655 | 3,675 | 3,630 | 3,660 | +15 | +0.4% | 169,400 |
| 2023/03/14 | 3,700 | 3,700 | 3,620 | 3,645 | -100 | -2.7% | 231,800 |
| 2023/03/13 | 3,720 | 3,760 | 3,705 | 3,745 | -20 | -0.5% | 235,600 |
| 2023/03/10 | 3,760 | 3,790 | 3,750 | 3,765 | +10 | +0.3% | 214,200 |
| 2023/03/09 | 3,730 | 3,775 | 3,725 | 3,755 | +20 | +0.5% | 121,300 |
| 2023/03/08 | 3,710 | 3,750 | 3,695 | 3,735 | -20 | -0.5% | 189,500 |
| 2023/03/07 | 3,730 | 3,765 | 3,730 | 3,755 | +15 | +0.4% | 121,100 |
| 2023/03/06 | 3,730 | 3,760 | 3,720 | 3,740 | +5 | +0.1% | 99,800 |
| 2023/03/03 | 3,730 | 3,740 | 3,715 | 3,735 | +15 | +0.4% | 92,400 |
| 2023/03/02 | 3,685 | 3,720 | 3,685 | 3,720 | +45 | +1.2% | 95,300 |
| 2023/03/01 | 3,750 | 3,755 | 3,675 | 3,675 | -95 | -2.5% | 189,700 |
| 2023/02/28 | 3,770 | 3,795 | 3,770 | 3,770 | -5 | -0.1% | 113,600 |
| 2023/02/27 | 3,775 | 3,805 | 3,765 | 3,775 | -50 | -1.3% | 141,300 |
| 2023/02/24 | 3,815 | 3,845 | 3,805 | 3,825 | +15 | +0.4% | 164,100 |
| 2023/02/22 | 3,790 | 3,815 | 3,775 | 3,810 | +5 | +0.1% | 197,400 |
| 2023/02/21 | 3,770 | 3,805 | 3,755 | 3,805 | +15 | +0.4% | 132,700 |
| 2023/02/20 | 3,810 | 3,820 | 3,765 | 3,790 | +5 | +0.1% | 124,200 |
| 2023/02/17 | 3,790 | 3,840 | 3,770 | 3,785 | -40 | -1% | 163,300 |
| 2023/02/16 | 3,820 | 3,880 | 3,805 | 3,825 | +45 | +1.2% | 191,700 |
| 2023/02/15 | 3,750 | 3,820 | 3,730 | 3,780 | -15 | -0.4% | 188,600 |
| 2023/02/14 | 3,940 | 3,945 | 3,750 | 3,795 | -160 | -4% | 335,900 |
| 2023/02/13 | 3,955 | 3,975 | 3,925 | 3,955 | +10 | +0.3% | 163,400 |
| 2023/02/10 | 3,905 | 3,955 | 3,900 | 3,945 | +15 | +0.4% | 114,800 |
| 2023/02/09 | 3,960 | 3,990 | 3,915 | 3,930 | -35 | -0.9% | 106,800 |
| 2023/02/08 | 3,945 | 4,000 | 3,945 | 3,965 | +45 | +1.1% | 88,000 |
| 2023/02/07 | 3,940 | 3,955 | 3,910 | 3,920 | -20 | -0.5% | 49,600 |
| 2023/02/06 | 3,905 | 3,950 | 3,905 | 3,940 | +50 | +1.3% | 55,000 |
| 2023/02/03 | 3,915 | 3,925 | 3,875 | 3,890 | -45 | -1.1% | 96,100 |
| 2023/02/02 | 4,020 | 4,035 | 3,935 | 3,935 | -80 | -2% | 118,400 |
| 2023/02/01 | 4,045 | 4,050 | 4,005 | 4,015 | ±0 | ±0% | 52,600 |
| 2023/01/31 | 4,000 | 4,030 | 3,985 | 4,015 | +25 | +0.6% | 80,800 |
| 2023/01/30 | 3,990 | 4,005 | 3,970 | 3,990 | +20 | +0.5% | 107,000 |
| 2023/01/27 | 3,990 | 4,000 | 3,960 | 3,970 | +10 | +0.3% | 72,100 |
| 2023/01/26 | 3,950 | 3,970 | 3,940 | 3,960 | +25 | +0.6% | 63,000 |
| 2023/01/25 | 3,930 | 3,960 | 3,930 | 3,935 | -10 | -0.3% | 54,600 |
401～
450
件表示中 / 893件
類似銘柄と比較する
現在ご覧いただいている「サワイＧＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サワイＧＨＤ | - | +4.0% | +25.4% | - | - | - |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | - | +56.7% | +357.2% | - | - | - |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 日本新薬 | - | +5.9% | 0.0% | - | - | - |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | - | +7.5% | - | - | - | - |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 科研薬 | - | +22.8% | +113.0% | - | - | - |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
